Immtech Pharmaceuticals, Inc.

Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.46(1)
from 10-K 8 pages Amended and Restated Employment Agreement
12/34/56
EX-10.50
from 10-Q 49 pages License Agreement Between Immtech Pharmaceuticals, Inc. and Bioalliance Pharma SA
12/34/56
EX-10.49
from 10-Q 12 pages Supply & Distribution Agreement Between Immtech Pharmaceuticals, Inc. and Par Pharmaceutical, Inc
12/34/56
EX-10.48
from 10-Q 33 pages Licensing Agreement Between Immtech Pharmaceuticals, Inc. and Par Pharmaceutical, Inc
12/34/56
EX-10
from 10-K ~10 pages Ex. 10.46(1): Sorkin Employment Agreement
12/34/56
EX-10
from 8-K ~50 pages Of Immtech Pharmaceuticals, Inc. Common Stock ($0.01 Par Value) Placement Agency Agreement
12/34/56
EX-10
from 8-K ~10 pages Employment Agreement
12/34/56
EX-10
from 8-K ~5 pages Stock Option Agreement Immtech Pharmaceuticals Inc. 2000 Stock Incentive Plan
12/34/56
EX-10
from 8-K ~5 pages Stock Option Agreement Immtech Pharmaceuticals Inc. 2000 Stock Incentive Plan
12/34/56
EX-10
from 10-Q/A ~10 pages May 1, 2006 T. Stephen Thompson 100 Pembroke Dr. Lake Forest, Il 60045 Re: Retirement and Consulting Agreement Dear Steve, This Letter, Upon Your Signature, Will Constitute Your Retirement and Consulting Agreement With Immtech Pharmaceuticals, Inc. (“Immtech” or the “Company”). Effective on the Above Date, (I) You Retire as President and a Director of Our Company and From All Other Positions You Hold With the Company and Its Subsidiaries and (II) You Become a Consultant to the Company
12/34/56
EX-10.2
from 8-K ~10 pages Amended/Restated Subcontract
12/34/56
EX-10.1
from 8-K ~20 pages Amend & Re. Consortium Lic. Agreement (Redacted)
12/34/56
EX-10.2
from 8-K ~5 pages Form of Common Stock
12/34/56
EX-10.1
from 8-K ~20 pages Form of Series E
12/34/56
EX-10.1
from 8-K ~5 pages Form of First Amendment to Lease
12/34/56
EX-10.3
from 8-K ~5 pages Stock Purchase Warrant
12/34/56
EX-10.2
from 8-K ~10 pages Form of Series D Regulation S Sub Agreement
12/34/56
EX-10.1
from 8-K ~10 pages Form of Series D Convertible Preferred Stock
12/34/56
EX-10.1
from 8-K ~20 pages Testing Agreement
12/34/56
EX-10.2
from 8-K ~20 pages Allonge to Share Purchase Agreement
12/34/56